The short version of shelf life fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-23. Anything still debated is marked as such rather than presented as settled.
The sequence now called GHK was first reported in the early 1970s after isolation from human plasma, where it was noted to influence liver cell behavior in laboratory preparations. Later work described a copper-binding form and its activity in fibroblast and wound-model experiments. Review articles frequently group the substance with other copper peptides. Concentrations in blood appear to fall with age in several small surveys, although the reason for this trend is not settled. Whether such a decline carries functional consequences remains an open question.
Published work on GHK-Cu concentrates largely on cell culture systems rather than whole organisms. Frequently used endpoints include collagen synthesis, expression of matrix metalloproteinases, and migration of fibroblasts. Some reports describe antioxidant behavior, while others stress delivery of copper into cells. These mechanisms are proposed rather than demonstrated, and the relative weight of each pathway is unclear. Human trials are few and generally small, so laboratory findings should not be read as confirmed clinical results.
Copper peptide solutions tend to resist degradation better than many free peptides, because the bound metal protects the N-terminus and reduces susceptibility to some peptidases. Backbone hydrolysis, oxidation of the histidine imidazole ring, and photochemical reactions remain the principal degradation routes. Aqueous solutions are generally most stable near neutral to mildly acidic pH, while strongly alkaline conditions accelerate hydrolysis. Light exposure is usually avoided, since both the peptide and the copper center can take part in photochemical processes. Stability data published by suppliers often describe short-term behavior rather than multi-year shelf life.
Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, frequently paired with mass spectrometry to confirm the molecular ion. Copper content is measured separately, typically by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy, because the chromatographic signal reports the peptide rather than the metal. Ultraviolet-visible spectroscopy provides a fast check on complex formation, since copper(II) peptide complexes absorb in the visible region. Elemental analysis and amino acid analysis are used less often but remain useful for reference standards. A gap between reported peptide purity and measured copper content is a recurring source of confusion.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Copper(II) peptide complex | Peptide chain coordinated to a single metal ion |
| CAS number | 89030-95-5 | Indexed for the peptide-copper complex |
| Molecular formula | C14H22CuN6O4 | Approximate formula for a one-to-one complex |
| Appearance | Blue to violet solid | Color from copper d-d transitions |
| Solubility class | Freely soluble in water | Also dispersible in some polar solvents |
Aqueous GHK-Cu solutions are less stable than the dry powder. Light, dissolved oxygen and elevated temperature all accelerate loss of the intact complex, and the main observable changes are fading of the blue colour and the appearance of peptide fragments. Acidic conditions protonate the histidine imidazole and weaken copper binding, while strongly alkaline conditions promote hydrolysis of the peptide backbone. Because several degradation routes operate at once, a single shelf-life figure does not describe all storage conditions.
Solid material is typically kept as a lyophilised powder in a sealed, light-protected container at minus 20 degrees Celsius, with desiccant where humidity is high. Working solutions are often prepared fresh, aliquoted and frozen to avoid repeated freeze-thaw cycles. Glassware and buffers are checked for trace metal contamination, since other transition metals can displace copper. Records of lot number, reconstitution date and storage temperature help trace unexpected colour changes. Blue colour itself is not a reliable purity test, because partly degraded solutions can remain visibly coloured.
Identity and purity are normally checked by reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry. The peptide absorbs in the ultraviolet region, and the copper complex also shows a broad visible absorption band that can be followed spectroscopically. Copper content is measured separately, for example by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy, because the peptide assay alone does not confirm how much metal is bound. Purity figures therefore need a stated basis: peptide peak area, copper content, or both.
The compound was first isolated from human plasma by the biochemist Loren Pickart in 1973. Early work identified it as a factor that altered the behavior of cultured liver cells, and later studies linked it to connective tissue and wound-related processes. Reported plasma concentrations fall markedly between roughly age twenty and age sixty, a pattern that generated interest in copper peptide biology. Whether that decline has functional consequences remains an open question, because differences observed across age groups do not by themselves establish causation. Research interest later expanded into cosmetic and tissue-culture settings.
Mechanistic accounts focus on how the complex delivers copper and how the released peptide interacts with the extracellular matrix. Copper is an essential cofactor for lysyl oxidase and other enzymes involved in collagen and elastin cross-linking, and GHK is one of several peptides able to carry the metal. Reported effects include altered gene expression in fibroblasts and changes in matrix metalloproteinase activity, although many of these findings come from cell culture rather than whole organisms. The relative contribution of the peptide backbone, the copper ion, and downstream copper metabolism is not fully resolved.
GHK-Cu is the copper-binding complex formed by the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The free peptide is usually written as GHK, and the complex is written as GHK-Cu or Cu-GHK. The sequence was identified in human plasma and later detected in saliva and urine. Its name comes from the single-letter codes of glycine, histidine and lysine. The complex is widely described as a naturally occurring carrier of copper in blood rather than as a free peptide with its own hormonal role.
Copper binds to the peptide through the histidine imidazole nitrogen and the terminal amino group, forming a stable square-planar complex. Binding constants reported for copper(II) with GHK are high, so the peptide competes effectively for copper in solution. The complex absorbs visible light, which gives solutions a blue to violet colour. Whether the metal-free peptide has a distinct biological function of its own is still an open question; some work treats it mainly as a copper delivery vehicle, while other work reports peptide-specific effects.
The compound was first isolated from human plasma in the 1970s by Loren Pickart, who later described copper-binding activity in liver and other tissues. Early reports focused on its presence in blood and its ability to carry copper between proteins. Commercial and cosmetic use of the term 'copper peptide' has since broadened, and labels rarely distinguish GHK-Cu from other copper-binding fragments. This naming overlap makes literature searching harder, because cosmetic ingredient lists, supplier catalogues and laboratory papers use different vocabularies for the same molecule.
5-HT2C receptor agonists are a class of drugs that activate 5-HT2C receptors. They have been investigated for the treatment of a number of conditions including obesity, psychiatric disorders, sexual dysfunction and urinary incontinence. The 5-HT2C receptors are one of three subtypes that belong to the serotonin 5-HT2 receptor subfamily along with 5-HT2A and 5-HT2B receptors. The development of 5-HT2C agonists has been a major obstacle, because of severe side effects due to a lack of selectivity. Activation of 5-HT2A receptors can induce hallucinations, and the activation of 5-HT2B receptors has been implicated in cardiac valvular insufficiency and possibly in pulmonary hypertension.
At the same time, the need for such a system was becoming increasingly pressing. In 1932, Winston Churchill and his friend, confidant and scientific advisor Frederick Lindemann travelled by car in Europe, where they saw the rapid rebuilding of the German aircraft industry. It was in November of that year that Stanley Baldwin gave his famous speech, stating that "The bomber will always get through". In the early summer of 1934, the RAF carried out large-scale exercises with up to 350 aircraft. The forces were split, with bombers attempting to attack London, while fighters, guided by the Observer Corps, attempted to stop them. The results were dismal. In most cases, the vast majority of the bombers reached their target without ever seeing a fighter. To address the one-sided results, the RAF gave increasingly accurate information to the defenders, eventually telling the observers where and when the attacks would be taking place. Even then, 70 per cent of the bombers reached their targets unhindered. The numbers suggested any targets in the city would be destroyed. Squadron Leader P. R. Burchall summed up the results by noting that "a feeling of defencelessness and dismay, or at all events of uneasiness, has seized the public." In November, Churchill gave a speech on "The threat of Nazi Germany" in which he pointed out that the Royal Navy could not protect Britain from an enemy who attacked by air. Through the early 1930s, a debate raged within British military and political circles about strategic airpower.
After the surrender of Nazi Germany, the Allies de jure abolished the German state and partitioned Berlin and Germany's remaining territory into four occupation zones. The western sectors, controlled by France, the United Kingdom, and the United States, were merged on 23 May 1949 to form the Federal Republic of Germany (FRG) (German: Bundesrepublik Deutschland; BRD); on 7 October 1949, the Soviet Zone became the German Democratic Republic (GDR) (Deutsche Demokratische Republik; DDR). They were informally known as West Germany and East Germany. East Germany selected East Berlin as its capital, while West Germany chose Bonn as a provisional capital to emphasize its stance that the two-state solution was temporary. West Germany was established as a federal parliamentary republic with a social market economy. In 1948, West Germany became a major recipient of reconstruction aid under the American Marshall Plan. Konrad Adenauer was elected the first federal chancellor of Germany in 1949. The country enjoyed prolonged economic growth (Wirtschaftswunder) beginning in the early 1950s. West Germany joined NATO in 1955 and was a founding member of the European Economic Community. On 1 January 1957, the Saarland joined West Germany. East Germany remained under political and military control by the Soviet Union via occupation forces and became an Eastern Bloc state, joining the Soviet-led Warsaw Pact and Comecon.
Sources: en.wikipedia.org
=== Business and markets === As of January 2021, Tetra Pak was operating in over 160 countries through its 29 market companies. Between 2007 and 2010, the company saw growth in emerging markets and opened new plants to meet that demand. Tetra Pak invested €100 million to build a plant in Russia in 2007, and built a €60 million plant in China the following year. In 2009, the company announced that it would invest more than €200 million to build plants in India and Pakistan to serve emerging markets in Asia and the Middle East, where milk consumption was rising, especially of ultra-high-temperature processed milk. At the time, two-thirds of Tetra Pak's global sales came from dairy packaging.
As the result of a program designed to develop a padding concept to improve crash protection for airplane passengers, Ames Research Center developed what is now called memory foam. Fagerdala World Foams managed to produce a mass-produced version in 1991, creating what they call "TEMPUR Foam". Memory foam has been incorporated into mattresses, pillows, military and civilian aircraft, automobiles and motorcycles, sports safety equipment, amusement park rides and arenas, horseback saddles, archery targets, furniture, and human and animal prostheses. Its high-energy absorption and soft characteristics offer protection and comfort. TEMPUR Foam was inducted into the Space Foundation Space Technology Hall of Fame in 1998.
== African Renaissance Institute == On October 11, 1999, the African Renaissance Institute (ARI) was founded in Pretoria. Its initial focuses were on the development of African human resources, science and technology, agriculture, nutrition and health, culture, business, peace, and good governance. In his book The African Renaissance, Washington Aggrey Jalang'o Okumu wrote that,
Sources: en.wikipedia.org
It is the copper complex of the tripeptide glycyl-L-histidyl-lysine. The metal ion is held by the histidine imidazole group and the peptide N-terminus. Most research on it concerns skin and wound models.
The tripeptide was first isolated from human plasma and has also been reported in saliva and urine. Plasma levels appear to decline with age in some small studies. Those observations rest on limited sample sizes.
It is not authorized as a systemic medicine in most countries. Cosmetic preparations list it as an ingredient rather than an active pharmaceutical substance. Legal status therefore differs by jurisdiction.
The solid is typically held cold and dry, and solutions are kept for shorter periods because hydrolysis proceeds in water. Repeated freeze-thaw cycles are usually avoided, since they can degrade both the peptide and the complex. Container material and headspace also affect how long a sample remains unchanged.